 number four that certainly should encourage us to look at more prevention efforts how those are being marketed we don't want those marketed looking like candies to children we also are seeing some of the opioids that are used for prevention that we think about with maintenance methadone buprenorphine and the pediatric age group the same thing we need to be careful as to what access children have to those